CIK 0001613103 · Large accelerated filer
Medtronic plc
Sign in to watch- Ticker
- MDT
- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Apr 24
- Entity type
- operating
- Phone
- 01135314381700
- Business address
- BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY, Ireland, H91 4K49
- Former names
- Medtronic Ltd, Medtronic Holdings Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,889,203
- in 3 filings, $5.8M under 10b5-1 plans
Net −$5,889,203. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-27 | Marinaro Michael EVP & President, Surgical OU | Shares withheld for taxes | −2,073 | $92.46 | $192K | 41,250 |
| 2025-01-27 | Marinaro Michael EVP & President, Surgical OU | Option exercise · Stock Option (Right to Buy) | −2,345 | 0 | ||
| 2025-01-27 | Martha Geoffrey Chairman and CEO | Option exercise | +34,741 | $74.84 | $2.6M | 216,954 |
| 2025-01-27 | Martha Geoffrey Chairman and CEO | Shares withheld for taxes | −30,184 | $92.46 | $2.8M | 186,770 |
| 2025-01-27 | Martha Geoffrey Chairman and CEO | Option exercise · Stock Option (Right to Buy) | −34,741 | 0 | ||
| 2025-01-24 | Wall Brett A. EVP & Pres Neuroscience | Option exercise 10b5-1 | +12,437 | $78.00 | $970K | 53,416 |
| 2025-01-24 | Wall Brett A. EVP & Pres Neuroscience | Sale 10b5-1 | −12,437 | $90.00 | $1.1M | 40,979 |
| 2025-01-24 | Wall Brett A. EVP & Pres Neuroscience | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,437 | 0 | ||
| 2025-01-21 | Corona Gary Louis Interim CFO | Grant or award | +11,315 | 44,255 | ||
| 2025-01-08 | Wall Brett A. EVP & Pres Neuroscience | Option exercise 10b5-1 | +6,850 | $74.84 | $513K | 50,558 |
| 2025-01-08 | Wall Brett A. EVP & Pres Neuroscience | Sale 10b5-1 | −6,850 | $80.41 | $551K | 43,708 |
| 2025-01-08 | Wall Brett A. EVP & Pres Neuroscience | Sale 10b5-1 | −3,000 | $80.41 | $241K | 40,708 |
| 2025-01-08 | Wall Brett A. EVP & Pres Neuroscience | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,850 | 0 | ||
| 2024-12-16 | Wall Brett A. EVP & Pres Neuroscience | Shares withheld for taxes | −645 | $82.48 | $53K | 43,708 |
| 2024-12-16 | Salmon Sean EVP & President Cardiovascular | Shares withheld for taxes | −645 | $82.48 | $53K | 64,722 |
| 2024-12-16 | Martha Geoffrey Chairman and CEO | Shares withheld for taxes | −4,417 | $82.48 | $364K | 181,326 |
| 2024-12-16 | Fong Ivan K EVP GENERAL COUNSEL & SECR | Shares withheld for taxes | −532 | $82.48 | $44K | 54,692 |
| 2024-12-10 | Fong Ivan K EVP GENERAL COUNSEL & SECR | Shares withheld for taxes | −3,009 | $83.58 | $251K | 55,224 |
| 2024-12-06 | Kirk Jennifer M Chief Accounting Officer | Shares withheld for taxes | −646 | $84.01 | $54K | 28,011 |
Page 12 of 12 · 239 trades